The Valley Desk

NCT02707861 · Interventional trial

Ibalizumab Plus Optimized Background Regimen in Treatment-Experienced Patients With Multi-Drug Resistant HIV-1

Overall registry status Completed

Phase 3

Conditions HIV

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov